TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/05/2026
Voltar para busca
Dado oficial do USPTO
MYCIT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MYCIT
ST13
US500000079267601Classe
5, 9, 10, 42, 44
Pedido
79267601
Registro
6132512
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
17/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
01/07/2019
Data de registro
25/08/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/08/2020
Última transação
17/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
94
Localização do titular
DE
Examinador
BROWN, TINA
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
B. S. (pessoa física)
Representantes
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for the treatment of cancerin particular based on nucleic acids and/or proteins; personalised patient-specific medicinal productsin particular based on nucleic acids and/or proteinspharmaceutical preparations for treatment of cancer diseasesautoimmune diseasesinfectious diseases
Classe 9
Scientific apparatuses and instrumentsnext generation sequencers for laboratory research use; software algorithmsdownloadable software programs for use in analyzing next generation sequencer datain particular for the detection and collection of mutations in cancer patients
Classe 10
High-throughput analytical instrumentsin particular instruments for next-generation sequencing (NGS) for medical issuesas well as for gene expression profiling and for the detection of epigenetic changeshigh throughput genome and exome gene sequencers for medical use
Classe 42
Medical research and development in the field of cancer immunotherapyin particular research and development in the field of human and veterinary medical diagnostics and treatment by means of molecular-biologicalgeneticbiotechnological and/or bioinformatic methodsin particular by means of next-generation sequencing; Scientific laboratory services and scientific research services featuring diagnostics of tumour markers for personalised treatment
Classe 44
Medicalveterinary-medical and pharmaceutical advisory servicesin particular in the selection of suitable treatments for cancer diseases of all kinds; Medical servicesperformance of analyses and treatments as part of personalised cancer immunotherapy; Medical services for the treatment of cancerprovision of treatments based on nucleic acids and/or checkpoint inhibitors
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15/05/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/05/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/05/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/05/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/05/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/03/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/08/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/04/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/12/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/12/2020
FIMP
FINAL DISPOSITION PROCESSED
01/12/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
25/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2020
PUBO
PUBLISHED FOR OPPOSITION
09/06/2020
GPNX
NOTIFICATION PROCESSED BY IB
05/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/05/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/04/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
15/03/2020
GNFR
FINAL REFUSAL E-MAILED
15/03/2020
CNFR
FINAL REFUSAL WRITTEN
15/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/02/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/02/2020
RFNT
REFUSAL PROCESSED BY IB
26/10/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/10/2019
RFRR
REFUSAL PROCESSED BY MPU
07/10/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/09/2019
MAFR
APPLICATION FILING RECEIPT MAILED
28/09/2019
CNRT
NON-FINAL ACTION WRITTEN
27/09/2019
DOCK
ASSIGNED TO EXAMINER
24/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/09/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MYCIT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.